BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 59332)

  • 1. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.
    Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH
    Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
    Bennett WM; Pastore L; Houghton DC
    Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
    Davis S; Kessler W
    Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck.
    Brown AW; Blom J; Butler WM; Garcia-Guerrero G; Richardson MF; Henderson RL
    Cancer; 1980 Jun; 45(11):2830-5. PubMed ID: 6155199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
    Lippman AJ; Helson C; Helson L; Krakoff IH
    Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
    Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
    Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis-diamminedichloroplatinum (II). A new anticancer drug.
    Rozencweig M; von Hoff DD; Slavik M; Muggia FM
    Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.
    Randolph VL; Vallejo A; Spiro RH; Shah J; Strong EW; Huvos AG; Wittes RE
    Cancer; 1978 Feb; 41(2):460-7. PubMed ID: 75760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)].
    Cappelaere P; Chauvergne J; Klein T; Gary-Bobo J; Guerrin J; Meeus L
    Bull Cancer; 1981; 68(5):422-7. PubMed ID: 6174165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
    Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
    Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
    Woods RL; Fox RM; Tattersall MH
    Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity.
    Salem P; Khalyl M; Jabboury K; Hashimi L
    Cancer; 1984 Feb; 53(4):837-40. PubMed ID: 6537893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies.
    Sarna G; Skinner DG; Smith RB; Zighelboim J; Goodnight JE; Feig S
    Cancer Treat Rep; 1980; 64(10-11):1077-82. PubMed ID: 7193086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
    Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
    Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigational chemotherapeutic agents in head and neck cancer.
    Rozencweig M; Von Hoff DD; Muggia FM
    Semin Oncol; 1977 Dec; 4(4):425-9. PubMed ID: 74096
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
    Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
    Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.